Evaluation of Anticancer Activity of Olmesartan and Ramipril on A549 Cell Line
E. Gayathri, K. Punnagai and D. Darling Chellathai

Department of Pharmacology, Sri Ramachandra Medical College and Research Institute, Chennai, India.

Corresponding Author E-mail: kpunnagai@yahoo.in

Abstract: Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin II type 1 receptor antagonist (ARBs) are the most efficient cardiovascular drugs and exhibited efficient cytostatic activity in vitro in many malignant and normal cells1.OBJECTIVE: This study aims to assess the anticancer activity of these two drugs in a dose dependant manner using A549 cell line through MTT assay and Cell cycle analysis.. MATERIALS AND METHODS: Ramipril and Olmesartan were added to A549 at various concentrations ranging from 10⁻⁶ to 10mM.The dot plot of the cytotoxicity results were used to extrapolate the IC50 values. The dot plot of flow cytometry results were used to extrapolate the DNA percentage in phases of cell cycle. The plates were read at 570 nm by using a PERCLIN ELMER (multimode reader). Measurements for concentration required for 50% inhibition was noted. RESULTS:  Ramipril and Olmesartan were added to A549 at various concentrations ranging from 10⁻⁶ to 10mM.The dot plot of the cytotoxicity results were used to extrapolate the IC50 values. The dot plot of flow cytometry results were used to extrapolate the DNA percentage in phases of cell cycle.

Keywords: Anticancer activity; Cell Cycle Analysis; Lung cancer; MTT assay; Olmesartan and Ramipril

[ HTML Full Text]

Back to TOC